Anti diabetic drug, Ayush-82 to hit the market soon

This ayurvedic formulation for management of diabetes developed by Central Council for Research in Ayurvedic Sciences (CCRAS) will be commercialized soon in the Indian market


New Delhi: Diabetes mellitus is a group of metabolic diseases marked by high level of blood glucose resulting from defects in insulin production, insulin action or both. Diabetes may lead to serious complications in multiple organ systems.

While there are many medicines in the market to control the sugar levels, now Ayush-82, an ayurvedic formulation for management of diabetes developed by Central Council for Research in Ayurvedic Sciences (CCRAS) will soon be commercialized. CCRAS along with the National Research Development Corporation (NRDC), an enterprise of the Department of Scientific and Industrial Research, Ministry of Science and Technology have entered into license agreement for commercialization of  Ayush-82 with Chaturbhuj Pharmaceutical, Haridwar.

The use of this cost effective drug would help millions of people suffering from diabetes. It is a combination of known and tested hypoglycemic drugs. Its clinical studies have been done extensively.

Ayush 82 Drug NRDCThe Licence agreement was signed by Dr H Purushotham, Chairman and Managing Director, on behalf of NRDC and Mr Murari Sharma, Proprietor, Chaturbhuj Pharmaceutical, Haridwar. NRDC has so far licensed 13 ayurvedic technologies developed by CCRAS to more than 33 companies in India.